Compare JAMF & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAMF | PRGO |
|---|---|---|
| Founded | 2002 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.1B |
| IPO Year | 2020 | 1991 |
| Metric | JAMF | PRGO |
|---|---|---|
| Price | $13.02 | $14.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $15.13 | ★ $20.33 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 7.88% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $690,590,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $15.30 | N/A |
| Revenue Next Year | $9.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.28 | N/A |
| 52 Week Low | $7.09 | $12.17 |
| 52 Week High | $16.12 | $30.93 |
| Indicator | JAMF | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 53.02 |
| Support Level | $13.00 | $14.18 |
| Resistance Level | $13.02 | $15.38 |
| Average True Range (ATR) | 0.02 | 0.52 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 50.00 | 57.81 |
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.